A unique presentation of Wiskott-Aldrich syndrome in relation to platelet size

Pediatric Blood and Cancer

Volumn 56, Issue 7, 2011, Pages 1127-1129

  Patel, Payal D ^a   Samanich, Joy M ^a   Mitchell, William B ^b   Manwani, Deepa ^a  

^a CHILDREN S HOSPITAL AT MONTEFIORE   (United States)

^b NEW YORK BLOOD CENTER   (United States)

Author keywords

Mean platelet volume; Size; Wiskott Aldrich syndrome

Indexed keywords

ARTICLE; CASE REPORT; CLINICAL FEATURE; GENE MUTATION; GENETIC ANALYSIS; GENETIC HETEROGENEITY; HUMAN; HUMAN CELL; INFANT; MALE; PHENOTYPE; PRIORITY JOURNAL; THROMBOCYTE; WISKOTT ALDRICH SYNDROME;

BLOOD PLATELETS; CELL SIZE; HUMANS; INFANT; MALE; MUTATION; PHENOTYPE; PLATELET COUNT; THROMBOCYTOPENIA; TREATMENT OUTCOME; WISKOTT-ALDRICH SYNDROME; WISKOTT-ALDRICH SYNDROME PROTEIN;

EID: 79954532590     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22920     Document Type: Article

References (17)

1. Bosticardo M, Marangoni F, Aiuti A, et al. Recent advances in understanding the pathophysiology of Wiskott-Aldrich syndrome. Blood 2009; 113: 6288-6295.
2. Notarangelo LD, Miao CH, Ochs HD. Wiskott Aldrich syndrome. Curr Opin Hematol 2008; 15: 30-36.
3. Ochs HD. Mutations of the Wiskott-Aldrich syndrome protein affect protein expression and dictate the clinical phenotype. Immunol Res 2009; 44: 84-88.
4. Stewart DM, Treiber-Held S, Kurman CC, et al. Studies of the expression of the Wiskott-Aldrich syndrome protein. J Clin Invest 1996; 97: 2627-2634.
5. Jin Y, Mazza C, Christie JR, et al. Mutations of the Wiskott-Aldrich Syndrome protein (WASP): Hotspots, effect on transcription, and translation and phenotype/genotype correlation. Blood 2004; 104: 4010-4019.
6. Litzman J, Jones A, Hann I, et al. Intravenous immunoglobulin, splenectomy, and antibiotic prophylaxis in Wiskott-Aldrich syndrome. Arch Dis Child 1996; 75: 436-439.
7. Strom TS. The thrombocytopenia of WAS: A familial form of ITP? Immunol Res 2009; 44: 42-53.
8. Corash L, Shafer B, Blaese RM. Platelet-associated immunoglobulin, platelet size, and the effect of splenectomy in the Wiskott-Aldrich syndrome. Blood 1985; 65: 1439-1443.
9. Shcherbina A, Rosen FS, Remold-O'Donnell E. Pathological events in platelets of Wiskott-Aldrich syndrome patients. Br J Haematol 1999; 106: 875-883.
10. Bouma G, Burns SO, Thrasher AJ. Wiskott-Aldrich syndrome: Immunodeficiency resulting from defective cell migration and impaired immunostimulatory activation. Immunobiology 2009; 214: 778-790.
11. Sellers WA, South MA. Wiskott-Aldrich syndrome with 18-year survival. Treatment with transfer factor. Am J Dis Child 1975; 129: 622-627.
12. Lin CY, Hsu HC. Acute immune complex mediated glomerulonephritis in a Chinese girl with Wiskott-Aldrich syndrome variant. Ann Allergy 1984; 53: 74-78.
13. Capsoni F, Acerbi L, Bonora G, et al. Phagocyte function and immunological findings in a Wiskott-Aldrich syndrome long-term survivor. J Clin Lab Immunol 1986; 19: 91-97.
14. Rocca B, Bellacosa A, De Cristofaro R, et al. Wiskott-Aldrich syndrome: Report of an autosomal dominant variant. Blood 1996; 87: 4538-4543.
15. Knox-Macaulay HH, Bashawri L, Davies KE. X linked recessive thrombocytopenia. J Med Genet 1993; 30: 968-969.
16. Filipovich AH, Stone JV, Tomany SC, et al. Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: Collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program. Blood 2001; 97: 1598-1603.
17. Ozsahin H, Cavazzana-Calvo M, Notarangelo LD, et al. Long-term outcome following hematopoietic stem-cell transplantation in Wiskott-Aldrich syndrome: Collaborative study of the European Society for Immunodeficiencies and European Group for Blood and Marrow Transplantation. Blood 2008; 111: 439-445 [Epub 2007 September 27].